Considering that NOS2 was one of the most significantly affected FRGs in our model (Supplementary Table 1) and the most obvious expression differences between patients in high risk and low risk groups (Figure 3A), we further investigated the role of NOS2 in ferroptosis-related tumor progression. The gene discussed is NOS2; the disease is neoplasm.